X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Bafna Pharmaceuticals Ltd.
BSE CODE: 532989   |   NSE CODE: BAFNAPH   |   ISIN CODE : INE878I01022   |   13-May-2024 Hrs IST
BSE NSE
Rs. 99.75
0 ( 0% )
 
Prev Close ( Rs.)
99.75
Open ( Rs.)
99.75
 
High ( Rs.)
99.75
Low ( Rs.)
99.75
 
Volume
15
Week Avg.Volume
9591
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 99.60
0 ( 0% )
 
Prev Close ( Rs.)
99.60
Open ( Rs.)
99.60
 
High ( Rs.)
99.60
Low ( Rs.)
99.60
 
Volume
384
Week Avg.Volume
15645
 
52 WK High-Low Range(Rs.)
75.9
124.45
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)4.79  2.21  2.46  -7.94  -8.34  
   CEPS(Rs)7.05  4.53  4.36  5.87  -6.89  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)31.05  26.19  24.00  -18.64  8.79  
   Tax Rate(%)2.40  0.00  0.00  0.00  -8.23  
Margin Ratios          
   Core EBITDA Margin(%)13.62  13.98  14.46  2.89  -29.95  
   EBIT Margin(%)11.84  7.06  9.22  -4.20  -36.91  
   Pre Tax Margin(%)10.07  6.13  8.18  -4.42  -41.79  
   PAT Margin (%)9.83  6.13  8.18  -4.42  -45.23  
   Cash Profit Margin (%)14.45  12.58  14.47  3.27  -37.38  
Performance Ratios          
   ROA(%)10.32  5.91  7.40  -1.96  -15.90  
   ROE(%)16.75  8.79  22.26  -22.93  -64.36  
   ROCE(%)16.12  8.42  10.62  -2.95  -20.90  
   Asset Turnover(x)1.05  0.96  0.90  0.44  0.35  
   Sales/Fixed Asset(x)1.26  1.02  0.93  0.58  0.60  
   Working Capital/Sales(x)2.82  2.95  2.81  2.26  -1.95  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.79  0.98  1.08  1.73  1.67  
   Receivable days88.49  52.17  39.96  132.64  205.45  
   Inventory Days67.24  76.57  68.82  88.92  83.48  
   Payable days118.26  105.56  133.55  586.42  512.64  
Valuation Parameters          
   PER(x)17.24  57.59  55.74  0.00  0.00  
   PCE(x)11.73  28.05  31.52  1.51  -1.59  
   Price/Book(x)2.66  4.85  5.72  -0.48  1.25  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)1.83  3.66  4.72  -0.08  1.59  
   EV/Core EBITDA(x)11.09  22.79  30.42  -2.27  -5.47  
   EV/EBIT(x)15.43  51.80  51.15  1.89  -4.31  
   EV/CE(x)1.63  3.45  3.89  -0.05  0.58  
   M Cap / Sales1.70  3.53  4.56  0.05  0.59  
Growth Ratio          
   Net Sales Growth(%)35.48  19.55  67.68  -2.65  -7.51  
   Core EBITDA Growth(%)39.00  23.66  644.34  111.70  -231.59  
   EBIT Growth(%)127.17  -8.50  468.50  88.93  -115.56  
   PAT Growth(%)117.34  -10.47  410.26  90.48  -19.94  
   EPS Growth(%)117.34  -10.47  131.03  4.82  -19.94  
Financial Stability Ratios          
   Total Debt/Equity(x)0.31  0.18  0.23  -0.68  2.22  
   Current Ratio(x)1.88  2.31  2.04  2.10  0.68  
   Quick Ratio(x)1.40  1.39  1.41  1.43  0.55  
   Interest Cover(x)6.70  7.57  8.85  -18.66  -7.57  
   Total Debt/Mcap(x)0.12  0.04  0.04  1.44  1.78